Ports of “Big Odessa” on Saturday and Sunday in the framework of the “Grain Initiative” sent 432 thousand tons of agricultural products in a caravan of nine ships to Africa, Asia and Europe, the Ministry of Infrastructure of Ukraine said.
“In particular, bulk carrier Honorine with 27.5 thousand tons of Ukrainian grain for Tunisia and bulk carrier Velvet with 57 thousand tons of wheat for Bangladesh,” the ministry noted.
The Ministry pointed out that 19 ships are being processed in the ports involved in the “grain initiative”, 630 thousand tons of Ukrainian agricultural products are being loaded on them.
At the same time, 94 ships are waiting for their turn to be inspected by the SKZ in the Bosporus (69 ships are empty for loading, and 25 are already loaded with agricultural products).
“The Russian side in the JCC is systematically slowing down inspections. Vessels wait more than a month on average. At the same time, the bulk carrier T-Med with wheat on board has been waiting for inspection since the beginning of November last year,” the Ministry of Infrastructure noted.
According to its information, at least 12 inspections per day are required for uninterrupted movement in the grain corridor.
A total of 620 vessels have left the ports of Greater Odessa since August 1, exporting 16.5 million tons of Ukrainian foodstuffs to Asia, Europe and Africa.
Kyiv-based producer of blood-derived products Biopharma is to boost exports by 60% in August 2018 year-over-year, to UAH 130 million. Exports in August will be 40% higher than the monthly average indicator during the year, the company’s press service said. In August 2018, the company will ship, in addition to Ukraine, to markets of 10 countries, including Belarus, Kazakhstan, India, Colombia, Uzbekistan, Azerbaijan, Middle East countries, as well as to Slovakia, Mongolia, and Bangladesh. It should be noted that Biopharma’s products will be delivered to Bangladesh and Colombia for the first time. The company’s plans include the expansion of its presence in the European markets.
Biopharma immunobiological pharmaceutical company is one of the ten largest Ukrainian producers of medicines. It produces more than 20 immunobiological preparations from donated blood, preparations obtained with the use of recombinant DNA technology and probiotics.
In 2015, the company invested $3.5 million in the reconstruction of Sumy region’s blood center, which currently accounts for 98.2% of donated blood in the region.
Biopharma plans to launch a plasma fractionation plant in 2018. The Biopharma Group of Companies includes LLC Biopharma Invest, LLC Biopharma Plasma Invest, LLC Biopharma Plasma, and LLC Fractionation Plant FZ Biopharma.
